Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
Official title: Development of a Recovery-Oriented Suicide Prevention Intervention With Peers for Clinical High Risk for Psychosis
Run by University of California, San Diego · NCT07756567 · Data updated 2026-11-12
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 30 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Status | Recruiting |
| Started | October 2026 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07756567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Young people (with clinical high risk for psychosis) who have had active suicide ideation or behavior and have a caregiver willing to participate, and who can read/write in English.
✕Probably not a fit
Patients without English literacy or without an eligible caregiver may be less likely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This hybrid effectiveness-implementation study develops and tests a recovery-oriented suicide prevention group tailored for youth at clinical high risk for psychosis. The intervention is led by a clinician and a peer with lived experience and includes caregiver participation. The study progresses from refinement and an open feasibility phase to a pilot randomized controlled trial comparing the intervention plus standard care versus standard care alone, with a final phase examining implementation factors in routine early psychosis services. It will be conducted over about three years at two early psychosis programs in California, using feedback from participants, caregivers, clinicians, and community advisors to optimize feasibility and fidelity. Primary outcomes focus on personal recovery and the use of suicide prevention strategies, with qualitative work to identify barriers and facilitators to future adoption.
Why it matters
Potential benefit: If successful, the program could improve personal recovery and increase use of suicide prevention strategies among youth at high risk for psychosis.
How similar studies have gone: Prior studies suggest peer-supported, recovery-oriented approaches can be beneficial in youth mental health, but this specific combination for CHR individuals is novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Young Person Inclusion Criteria: * symptoms of clinical high risk for psychosis in the last two years * lifetime active suicide ideation and/or lifetime suicide behavior * has a caregiver willing to participate Young Person Exclusion Criterion: * not able to read and write in English Caregiver Inclusion Criteria: * has a familial relationship with the young person participant * has at least 4 hours of face-to-face contact with the patient participant every week, even if they do not live together Caregiver Exclusion Criteria: None \*\*\* Administrator/Clinician Inclusion Criteria: * employed at the University of California, San Diego or University of California, Los Angeles early psychosis program Administrator/Clinician Exclusion Criteria: None
Where it's running
-
University of California, Los Angeles
Los Angeles, California, United States Recruiting -
University of California, San Diego
San Diego, California, United States Recruiting
Study contacts
- Study coordinator: Samantha Chalker, PhD
- Email: schalker@health.ucsd.edu
- Phone: 619-821-9415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital sleep treatment for teens with insomnia after hospitalization
This project will try a six-session digital cognitive behavioral therapy for insomnia (Sleepio) plus usual care to see if it helps 14–18-year-olds recently hospitalized for suicide risk who have insomnia.
-
Shame-focused cognitive behavioral therapy to reduce suicide risk in hospitalized teens
This program will test whether shame-focused cognitive behavioral therapy helps hospitalized teens (ages 13–18) with recent suicide attempts or severe suicidal thoughts reduce shame and lower suicide risk.
-
Tracking suicide attempts and suicidal thoughts in Flanders
This project collects detailed information about people in Flanders who have suicidal thoughts or who have survived suicide attempts to see how often these events happen, which methods are used, and whether they get follow-up care.
-
App-based safety planning and supports for teens and young adults with suicidal thoughts
This project will test whether an app that helps teens and young adults (ages 13–21) create safety plans and access coping and support resources can improve youth coping, parent confidence, and clinician self-efficacy.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
Understanding Impulsivity in Adolescents with Suicidal Behavior
This study is trying to see how impulsive actions during tough emotions relate to brain activity in teenagers aged 13-21 who have depression and suicidal thoughts or behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.